CoChat

Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy

Geuens, Sam, Van Dessel, Jeroen, Govaarts, Rosanne, Ikelaar, Nadine A., Meijer, Onno C., Kan, Hermien E., Niks, Erik H., Goemans, Nathalie, Lemiere, Jurgen, Doorenweerd, Nathalie, De Waele, Liesbeth · 2023 · Annals of Clinical and Translational Neurology
Cited by 11

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective: Duchenne muscular dystrophy (DMD) is a neuromuscular disorder in which many patients also have neurobehavioral problems. Corticosteroids, the primary pharmacological treatment for DMD, have been shown to affect brain morphology in other conditions, but data in DMD are lacking. This study aimed to investigate the impact of two corticosteroid regimens on brain volumetrics in DMD using magnetic resonance imaging (MRI). Methods: In a cross‐sectional, two‐center study, T1‐weighted MRI scans were obtained from three age‐matched groups (9–18 years): DMD patients treated daily with deflazacort (DMDd, n = 20, scan site: Leuven), DMD patients treated intermittently with prednisone (DMDi, n = 20, scan site: Leiden), and healthy controls (n = 40, both scan sites). FSL was used to perform voxel‐based morphometry analyses and to calculate intracranial, total brain, gray matter, white matter, and cerebrospinal fluid volumes. A MANCOVA was employed to compare global volumetrics between groups, with site as covariate. Results: Both patient groups displayed regional differences in gray matter volumes compared to the control group. The DMDd group showed a wider extent of brain regions affected and a greater difference overall. This was substantiated by the global volume quantification: the DMDd group, but not the DMDi group, showed significant differences in gray matter, white matter, and cerebrospinal fluid volumes compared to the control group, after correction for intracranial volume. Interpretation: Volumetric differences in the brain are considered part of the DMD phenotype. This study suggests an additional impact of corticosteroid treatment showing a contrast between pronounced alterations seen in patients receiving daily corticosteroid treatment and more subtle differences in those treated intermittently.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acn3.51922

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 51

  1. 10.3233/JND-140045 · DOI · Paper page
  2. 10.1016/S1474-4422(18)30024-3 · DOI · Paper page
  3. 10.3390/genes11080837 · DOI · Paper page
  4. 10.1001/jama.2022.4315 · DOI · Paper page
  5. 10.1038/s41598-017-12981-5 · DOI · Paper page
  6. 10.1002/mus.26803 · DOI · Paper page
  7. 10.1111/dmcn.12922 · DOI · Paper page
  8. 10.1016/j.jpeds.2012.03.020 · DOI · Paper page
  9. 10.1212/WNL.0000000000008363 · DOI
  10. 10.3390/brainsci12111544 · DOI
  11. 10.1002/ana.24222 · DOI · Paper page
  12. 10.1016/j.nmd.2020.05.001 · DOI
  13. 10.3174/ajnr.A6604 · DOI · Paper page
  14. 10.1007/s00415-021-10789-y · DOI · Paper page
  15. 10.1002/mus.10238 · DOI · Paper page
  16. 10.1002/nbm.1582 · DOI · Paper page
  17. 10.1016/j.nmd.2016.10.005 · DOI
  18. 10.1016/j.nmd.2022.02.008 · DOI
  19. 10.1016/j.nmd.2020.08.357 · doi:10.1016/j.nmd.2020.08.357
  20. 10.1016/j.brainres.2009.03.036 · DOI
  21. De Kloet ER, 1998, Brain corticosteroid receptor balance in health and disease, Endocr Rev, 19, 269
  22. 10.1159/000101917 · DOI · Paper page
  23. 10.3389/fnins.2021.604103 · DOI · Paper page
  24. 10.1016/j.nicl.2019.101825 · DOI
  25. 10.1038/pr.2017.312 · DOI
  26. 10.1111/apa.13010 · DOI
  27. Meulen M, 2022, Association between use of systemic and inhaled glucocorticoids and changes in brain volume and white matter microstructure: a cross‐sectional study using data from the UK biobank, BMJ Open, 12, 10.1136/bmjopen-2022-062446 · DOI · Paper page
  28. 10.1016/j.biopsych.2003.09.010 · DOI · Paper page
  29. 10.1016/S0893-133X(99)00054-8 · DOI · Paper page
  30. 10.1016/j.biopsych.2007.09.014 · DOI
  31. 10.1097/JCP.0000000000001120 · DOI
  32. 10.1176/appi.ajp.2014.13091264 · DOI · Paper page
  33. 10.1080/15622975.2019.1585946 · DOI
  34. 10.1016/j.neuroimage.2011.09.015 · DOI · Paper page
  35. 10.1016/j.neuroimage.2004.07.051 · DOI · Paper page
  36. 10.1016/j.neuroimage.2008.10.055 · DOI · Paper page
  37. 10.1006/nimg.2002.1132 · DOI · Paper page
  38. 10.1016/S1361-8415(01)00036-6 · DOI · Paper page
  39. 10.1002/hbm.10062 · DOI · Paper page
  40. 10.1109/42.906424 · DOI · Paper page
  41. 10.1093/brain/awm184 · DOI · Paper page
  42. 10.1006/nimg.2001.0786 · DOI · Paper page
  43. IBM Corp, 2021, IBM SPSS Statistics
  44. 10.1038/s41398-020-00980-6 · DOI
  45. 10.1097/MED.0000000000000414 · DOI
  46. 10.1016/j.neuroscience.2019.05.050 · DOI
  47. 10.1212/WNL.0000000000002337 · DOI · Paper page
  48. 10.1016/j.pmr.2012.08.003 · DOI
  49. 10.1212/WNL.0000000000001950 · DOI · Paper page
  50. 10.1155/2015/450341 · DOI · Paper page
  51. 10.1002/jmri.22576 · DOI

Cited by

Metadata

Authors
Geuens, S., Van Dessel, J., Govaarts, R., Ikelaar, N. A., Meijer, O. C., Kan, H. E., Niks, E. H., Goemans, N., Lemiere, J., Doorenweerd, N., & De Waele, L.
Affiliations
  • Child Neurology University Hospitals Leuven Leuven Belgium
  • Department of Neurosciences, Center for Developmental Psychiatry UPC‐KU Leuven Leuven Belgium
  • C.J. Gorter MRI Center, Radiology Leiden University Medical Center Leiden Netherlands
  • Duchenne Center Netherlands Leiden Netherlands
  • Department of Medicine Leiden University Medical Center Leiden Netherlands
  • Pediatric Hemato‐Oncology University Hospitals Leuven Leuven Belgium
Venue
Annals of Clinical and Translational Neurology
Publisher
Wiley
Published
2023-10-12
Volume
10
Issue
12
Pages
2324-2333
ISSN
2328-9503
Cited by
11
References
4
Language
en
Funders
Rondoufonds voor Duchenneonderzoek

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.